Role of Helicobacter Pylori Infection and Nonsteroidal Anti-Inflammatory Drug Use in Bleeding Peptic Ulcers
Anti-Inflammatory Drug Use in Bleeding Peptic Ulcers
DOI:
https://doi.org/10.54393/pjhs.v4i03.555Keywords:
Helicobacter pylori, NSAID, Bleeding Peptic UlcersAbstract
Most peptic ulcers and their complications are caused by Helicobacter pylori and nonsteroidal anti-inflammatory drugs (NSAIDs). Objective: To characterize the bleeding peptic ulcers features. Methods: This prospective study was carried out on 124 cases in the Department of Gastroenterology, Lady Reading Hospital in collaboration with Pharmacology Unit of Khyber Medical University, Peshawar from July 2018 to June 2020. All the patients were categorized into four groups: Positive H. pylori and no NSAID history (Group I), Positive H. pylori and NSAID use (Group-II), Negative H. pylori and NSAID user (Group-III), and Negative H. pylori and no NSAID history (Group-IV). Data analysis was carried out in SPSS version 26. Results: Of the total 124 cases, the prevalence of positive and negative H. pylori infection was 77.4% (n=96) and 22.6% (n=28) respectively. The number of patients in group I, II, III, and IV patients were 80 (64.5%), 16 (12.9%), 17 (13.7%), and 11 (8.9%) respectively. The incidence of NSAID users were 33 (26.6%) patients, out of which 18 used on daily basis and 15 on demand. Those in groups I and IV were substantially younger than groups II and III and they had less comorbid disorders than patients in group I. Conclusion: The present study concluded that about 26.6% of patients with bleeding ulcers took NSAIDs, meaning that low-dose aspirin will cause bleeding ulcers as will NSAID use on-demand.
References
Venerito M, Schneider C, Costanzo R, Breja R, Röhl FW, Malfertheiner P. Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti‐inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors. Alimentary Pharmacology & Therapeutics. 2018 Jun; 47(11): 1464-71. doi: 10.1111/apt.14652
Franck C, Hoffmann A, Link A, Schulz C, Wuttig K, Becker E, et al. Prevalence of Helicobacter pylori infection among blood donors in Saxony-Anhalt, Germany-a region at intermediate risk for gastric cancer. Zeitschrift für Gastroenterologie. 2017 Jul; 55(07): 653-6. doi: 10.1055/s-0043-106311
Laursen SB, Stanley A, Leontiadis G, Hallas J, de Muckadell OB. Use of selective serotonin receptor inhibitors (SSRIs) is not Associated with increased risk of endoscopy-refractory bleeding, rebleeding or mortality in patients with peptic ulcer bleeding. Gastroenterology. 2016; 150(4): S164-5. doi: 10.1016/S0016-5085(16)30646-1
Seo SI, Kang JG, Kim HS, Shin WG, Jang MK, Lee JH, et al. Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, and low-dose aspirin therapy in peptic ulcer disease: a case-control study. The Korean Journal of Helicobacter and Upper Gastrointestinal Research. 2019 Mar; 19(1): 42-7. doi: 10.7704/kjhugr.2019.19.1.42
Liang CM, Yang SC, Wu CK, Li YC, Yeh WS, Tai WC, et al. Risk of recurrent peptic ulcer disease in patients receiving cumulative defined daily dose of nonsteroidal anti-inflammatory drugs. Journal of Clinical Medicine. 2019 Oct; 8(10). doi: 10.3390/jcm8101722
Lee MW and Katz PO. Nonsteroidal anti-inflammatory drugs, anticoagulation, and upper gastrointestinal bleeding. Clinics in Geriatric Medicine. 2021 Feb; 37(1): 31-42. doi: 10.1016/j.cger.2020.08.004
Liang CM, Hsu CN, Tai WC, Yang SC, Wu CK, Shih CW, et al. Risk factors influencing the outcome of peptic ulcer bleeding in chronic kidney disease after initial endoscopic hemostasis: A nationwide cohort study. Medicine. 2016 Sep; 95(36). doi: 10.1097/MD.0000000000004795
Hooi JK, Lai WY, Ng WK, Suen MM, Underwood FE, Tanyingoh D, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017 Aug; 153(2): 420-9. doi: 10.1053/j.gastro.2017.04.022
Dinçer D, Karancı EU, Akın M, Adanır H. NSAID, antiaggregant, and/or anticoagulant-related upper gastrointestinal bleeding: Is there any change in prophylaxis rate after a 10-year period?. The Turkish Journal of Gastroenterology. 2019 Jun; 30(6): 505-10. doi: 10.5152/tjg.2019.18466
Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection-the Maastricht IV/Florence consensus report. Gut. 2012 May; 61(5): 646-64. doi: 10.1136/gutjnl-2012-302084
Sostres C, Gargallo CJ, Lanas A. Interaction between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs and/or low-dose aspirin use: Old question new insights. World journal of gastroenterology: WJG. 2014 Jul; 20(28): 9439-50.
Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of Helicobacter pylori infection. Official journal of the American College of Gastroenterology| ACG. 2017 Feb; 112(2): 212-39. doi: 10.1038/ajg.2016.563
Seo SI, Kang JG, Kim HS, Shin WG, Jang MK, Lee JH, et al. Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, and low-dose aspirin therapy in peptic ulcer disease: a case-control study. The Korean Journal of Helicobacter and Upper Gastrointestinal Research. 2019 Mar; 19(1): 42-7. doi: 10.7704/kjhugr.2019.19.1.42
Sostres C, Carrera-Lasfuentes P, Benito R, Roncales P, Arruebo M, Arroyo MT, et al. Peptic ulcer bleeding risk. The role of Helicobacter pylori infection in NSAID/low-dose aspirin users. Official journal of the American College of Gastroenterology| ACG. 2015 May; 110(5): 684-9. doi: 10.1038/ajg.2015.98
Kurata JH and Nogawa AN. Meta-analysis of risk factors for peptic ulcer: nonsteroidal antiinflammatory drugs: Helicobacter pylori: and smoking. Journal of clinical gastroenterology. 1997 Jan; 24(1): 2-17. doi: 10.1097/00004836-199701000-00002
Meucci G, Di Battista R, Abbiati C, Benassi R, Bierti L, Bortoli A, et al. Prevalence and risk factors of Helicobacter pylorinegative peptic ulcer: a multicenter study. Journal of clinical gastroenterology. 2000; 31: 42-7. doi: 10.1097/00004836-200007000-00010
Henriksson AE, Edman AC, Nilsson I, Bergqvist D, Wadström T. Helicobacter pylori and the relation to other risk factors in patients with acute bleeding peptic ulcer. Scandinavian journal of gastroenterology. 1998 Jan; 33(10): 1030-3. doi: 10.1080/003655298750026705
Nishikawa K, Sugiyama T, Kato M, Ishizuka J, Komatsu Y, Kagaya H, et al. Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese population. European Journal of Gastroenterology & Hepatology. 2000; 12: 635-40. doi: 10.1097/00042737-200012060-00010
Ishibashi S, Iwakiri R, Shimoda R, Ootani H, Kawasaki S, Tadano J, et al. Normalization of phospholipids concentration of the gastric mucosa was observed in patients with peptic ulcer after eradication of Helicobacter pylori. Helicobacter. 2002; 7(4): 245-9. doi: 10.1046/j.1523-5378.2002.00086.x
Gisbert JP, Gonzalez L, De Pedro A, Valbuena M, Prieto B, Llorca I, et al. Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs. Scandinavian journal of gastroenterology. 2001 Jan; 36(7): 717-24. doi: 10.1080/003655201300191978
Chan HL, Wu JC, Chan FK, Choi CL, Ching JY, Lee YT, et al. Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients. Gastrointestinal endoscopy. 2001 Apr; 53(4): 438-42. doi: 10.1067/mge.2001.112840
Lee JM, Breslin NP, Fallon C, O'morain CA. Rapid urease tests lack sensitivity in Helicobacter pylori diagnosis when peptic ulcer disease presents with bleeding. The American journal of gastroenterology. 2000 May; 95(5): 1166-70. doi: 10.1111/j.1572-0241.2000.02004.x
Higham J, Kang JY, Majeed A. Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of haemorrhage among older subjects. Gut. 2002 Apr; 50(4): 460-4. doi: 10.1136/gut.50.4.460
Ciubotaru AD and Leferman CE. Case Report: Peptic ulcer disease following short-term use of nonsteroidal anti-inflammatory drugs in a 3-year-old child. F1000Research. 2021 Jun; 9(419). doi: 10.12688/f1000research.24007.2
Kalach N, Bontems P, Koletzko S, Mourad-Baars P, Shcherbakov P, Celinska-Cedro D, et al. Frequency and risk factors of gastric and duodenal ulcers or erosions in children: a prospective 1-month European multicenter study. European journal of gastroenterology & hepatology. 2010 Oct; 22(10): 1174-81. doi: 10.1097/MEG.0b013e32833d36de
Cardile S, Martinelli M, Barabino A, Gandullia P, Oliva S, Di Nardo G, et al. Italian survey on non-steroidal anti-inflammatory drugs and gastrointestinal bleeding in children. World journal of gastroenterology. 2016 Feb; 22(5): 1877-83. doi: 10.3748/wjg.v22.i5.1877
Koh JS and Joo MK. The role of Helicobacter pylori infection in drug-induced peptic ulcer. The Korean Journal of Helicobacter and Upper Gastrointestinal Research. 2018 Jun; 18(2): 89-94. doi: 10.7704/kjhugr.2018.18.2.89
Gwee KA, Goh V, Lima G, Setia S. Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits. Journal of Pain Research. 2018 Feb: 361-74. doi: 10.2147/JPR.S156938
Nasher O, Devadason D, Stewart RJ. Upper gastrointestinal bleeding in children: a tertiary united kingdom children's hospital experience. Children. 2017 Nov; 4(11). doi: 10.3390/children4110095
Thomson MA, Leton N, Belsha D. Acute upper gastrointestinal bleeding in childhood: development of the Sheffield scoring system to predict need for endoscopic therapy. Journal of Pediatric Gastroenterology and Nutrition. 2015 May; 60(5): 632-6. doi: 10.1097/MPG.0000000000000680
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments
